bimekizumab
ucb pharmaceuticals
['be mobile', 'bimekizumab', 'achieve,(-u achieve),(-u-achieve),(-uachieve)']
il17a/fi bimekizumab bkz to wk 24 achieved reduction in total spinal pain (sp) nocturnal sp morning stiffness (basdai) fatigue (facit-f) deodhar et al, be mobile 1,2 abst 0409 #acr22 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Leader,NASS Trustee &Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach